Starting January 5, 2026, Novo Nordisk begins selling its FDA-approved Wegovy weight-loss pill in the US at lower self-pay ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

Wegovy for weight loss is a medical treatment that mimics a natural gut hormone to suppress hunger and support significant, ...

Complete Pricing Comparison Shows FDA-Approved Wegovy Access From $149 Oral to Ro's $199 Injectable Through Telehealth as 1 in 8 Americans Now Use GLP-1 MedicationsNEW YORK, Dec. 30, 2025 (GLOBE ...

Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to reality. On December 22, the U.S. Food and Drug Administration (FDA) approved ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...